Lung cancer screening and its efficacy

Area of Science:

• Pulmonology
• Oncology
• Preventive Medicine

Background:

• Lung cancer screening efficacy is debated, with historical trials yielding inconclusive results.
• Survival rates can be misleading due to various biases, making population mortality a more reliable metric.
• Recent Japanese case-control studies indicate significant risk reduction for lung cancer deaths with current screening methods.

Purpose of the Study:

• To evaluate the true efficacy of lung cancer screening.
• To compare the effectiveness of different lung cancer screening methodologies.
• To advocate for the implementation of rigorous randomized controlled trials in Japan.

Main Methods:

• Review of historical randomized controlled trials (RCTs) from the 1970s-1980s in Europe and the US.
• Analysis of recent Japanese case-control studies on lung cancer screening.
• Examination of preliminary reports on thoracic computed tomography (CT) screening for lung cancer.

Main Results:

• Past RCTs failed to demonstrate a decrease in lung cancer mortality.
• Japanese case-control studies suggest a 30%-60% reduction in lung cancer death risk.
• Preliminary thoracic CT screening reports show high detection and survival rates, but potential biases exist.

Conclusions:

• Lung cancer screening efficacy requires evaluation based on population mortality, not patient survival rates, to mitigate bias.
• While promising, the actual efficacy of current lung cancer screening remains uncertain pending further investigation.
• Immediate initiation of randomized controlled trials in Japan is recommended to definitively assess screening effectiveness.